Nuclear magnetic resonance-determined lipoprotein profile and risk of breast cancer: a Mendelian randomization study.
Xiao J, Hao Y, Wu X, Zhao X, Xu B, Xiao C, Zhang W, Zhang L, Cui H, Yang C, Yan P, Tang M, Wang Y, Chen L, Liu Y, Zou Y, Yang C, Yao Y, Li J, Jiang X, Zhang B.
Xiao J, et al. Among authors: zhang l, zhang b, zhang w.
Breast Cancer Res Treat. 2023 Jul;200(1):115-126. doi: 10.1007/s10549-023-06930-2. Epub 2023 May 10.
Breast Cancer Res Treat. 2023.
PMID: 37162625